Deals Of The Year: Cast Your Vote For Top M&A Of 2017
It's time for In Vivo's 10th annual Deal of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners. (It's free.)
You may also be interested in...
Already partnered with Kite to apply two technology platforms to CAR-T candidates, Cell Design adds to Gilead's immuno-oncology expertise. Analysts expect more add-ons for Gilead's increasing IO focus.
The pharmacy retail chain and drug distributor will buy the insurer for $69bn in a merger to build what the companies say will be a new, more affordable healthcare concept.
Express Scripts points to a relatively untapped market of 30m uninsured individuals who could be reached through a collaboration with Amazon if the e-commerce giant ventures into Rx drug sales.